Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Clinical Calcium|June 30, 2010
[CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder]Masahide Mizobuchi, Yumie Aoshima, Tadao AkizawaClinical and Experimental Hypertension (New York, N.Y. : 1993)|December 14, 2011
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patientsHirokazu Honda, Nozomu Hosaka, Yumie Aoshima, et al.Internal Medicine (Tokyo, Japan)|September 3, 2013
Membranous nephropathy that first presented in pregnancyYumie Aoshima, Masayuki Iyoda, Ai Nakazawa, et al.Internal Medicine (Tokyo, Japan)|August 20, 2010
A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levelsYoshihiro Kuno, Masayuki Iyoda, Yumie Aoshima, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 31, 2012
Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-αYumie Aoshima, Masahide Mizobuchi, Hiroaki Ogata, et al.Pageof 1